Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction

Benzer Materyaller

• A redesigned follitropin alfa pen injector for infertility: results of a market research study
  Yazar:: Abbotts, Carole, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study
  Yazar:: Welcker, J Thomas, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology
  Yazar:: Bühler, Klaus, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Human factors engineering and design validation for the redesigned follitropin alfa pen injection device
  Yazar:: Mahony, Mary C, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment
  Yazar:: Illingworth, Peter J, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)